Ovid Therapeutics Inc. (OVID) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 160.15M | 90.45M | 28.82M | 42.09M | 45.92M | 55.94M | 65.83M | 80.89M | 93.17M | 109.6M | 91.71M | 102.17M |
| Cash & Short-Term Investments | 155.52M | 69.64M | 25.6M | 38.35M | 43M | 53.08M | 62.71M | 76.97M | 90.26M | 105.83M | 87.07M | 96.52M |
| Cash Only | 94.06M | 13.15M | 20.61M | 28.41M | 21.14M | 26.3M | 15.02M | 29.69M | 30.77M | 27.04M | 57.44M | 71.62M |
| Short-Term Investments | 61.46M | 56.48M | 4.99M | 9.93M | 21.86M | 26.77M | 47.7M | 47.28M | 59.49M | 78.79M | 29.64M | 24.89M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 4.62M | 20.81M | 3.22M | 0 | 0 | 0 | 0 | 3.92M | 0 | 1K | 0 | 0 |
| Total Non-Current Assets | 65.48M | 60.49M | 35.02M | 35.34M | 35.73M | 36.23M | 36.83M | 37.2M | 38.44M | 34.43M | 33.32M | 34.06M |
| Property, Plant & Equipment | 11.52M | 0 | 12.19M | 12.5M | 12.86M | 13.23M | 13.59M | 13.97M | 14.31M | 14.66M | 15.01M | 15.37M |
| Fixed Asset Turnover | - | - | 0.01x | 0.49x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 38K | 92K | 155K | 219K | 148K | 200K | 222.05K | 263.37K |
| Long-Term Investments | 41.96M | 64.7M | 20.91M | 20.91M | 20.91M | 20.97M | 21.13M | 22.98M | 22.02M | 17.63M | 16.12M | 16.47M |
| Other Non-Current Assets | 12.01M | -4.22M | 1.93M | 1.93M | 1.93M | 1.93M | 1.96M | 27K | 1.96M | 1.94M | 1.96M | 1.96M |
| Total Assets | 225.63M | 150.93M | 63.85M | 77.43M | 81.65M | 92.17M | 102.65M | 118.09M | 131.61M | 144.03M | 125.03M | 136.23M |
| Asset Turnover | - | 0.01x | 0.00x | 0.08x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Asset Growth % | 176.32% | 63.76% | -37.8% | -34.43% | -37.96% | -36.01% | -17.9% | -13.31% | -8.2% | -7.24% | -24.24% | -23.18% |
| Total Current Liabilities | 15.75M | 8.29M | 6.8M | 8.92M | 9.31M | 10.52M | 11.63M | 14.12M | 8.9M | 11.47M | 8.66M | 10.14M |
| Accounts Payable | 8.88M | 1.96M | 1.71M | 3.95M | 1.95M | 3.19M | 2.71M | 4.72M | 3.6M | 3.7M | 1.22M | 3.76M |
| Days Payables Outstanding | 13.93K | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 1.46M | 0 | 0 | 0 | 0 | 0 | 0 | 1.29M | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 718K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 5.41M | 1.79M | 0 | 718K | 0 | 1K | 0 | 3.16M | 1 | 0 | 0 | 0 |
| Current Ratio | 10.17x | 10.91x | 4.24x | 4.72x | 4.93x | 5.32x | 5.66x | 5.73x | 10.47x | 9.55x | 10.59x | 10.07x |
| Quick Ratio | 10.17x | 10.91x | 4.24x | 4.72x | 4.93x | 5.32x | 5.66x | 5.73x | 10.47x | 9.55x | 10.59x | 10.07x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 11.61M | 11.99M | 12.35M | 12.71M | 13.07M | 13.42M | 14.73M | 15.07M | 44.43M | 44.76M | 15.07M | 15.39M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 972K | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 11.99M | 12.35M | 12.71M | 13.07M | 13.42M | 13.76M | 14.1M | 14.43M | 14.76M | 15.07M | 15.39M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 11.61M | 0 | 0 | 0 | 1K | 0 | 972K | 0 | 30M | 30M | 0 | 0 |
| Total Liabilities | 27.36M | 20.27M | 19.15M | 21.64M | 22.38M | 23.94M | 26.36M | 29.19M | 53.33M | 56.23M | 23.74M | 25.53M |
| Total Debt | 1.46M | 13.42M | 13.76M | 14.1M | 14.43M | 14.76M | 15.07M | 16.36M | 15.7M | 16M | 16.3M | 16.33M |
| Net Debt | -92.61M | 266K | -6.85M | -14.32M | -6.71M | -11.55M | 58K | -13.33M | -15.07M | -11.04M | -41.14M | -55.29M |
| Debt / Equity | 0.01x | 0.10x | 0.31x | 0.25x | 0.24x | 0.22x | 0.20x | 0.18x | 0.20x | 0.18x | 0.16x | 0.15x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 198.27M | 130.66M | 44.7M | 55.79M | 59.28M | 68.23M | 76.29M | 88.9M | 78.28M | 87.8M | 101.29M | 110.7M |
| Equity Growth % | 234.48% | 91.51% | -41.41% | -37.25% | -24.28% | -22.29% | -24.68% | -19.69% | -35.28% | -33.62% | -28.69% | -27.24% |
| Book Value per Share | 2.69 | 1.60 | 0.63 | 0.78 | 0.83 | 0.96 | 1.07 | 1.25 | 1.11 | 1.24 | 1.43 | 1.57 |
| Total Shareholders' Equity | 198.27M | 130.66M | 44.7M | 55.79M | 59.28M | 68.23M | 76.29M | 88.9M | 78.28M | 87.8M | 101.29M | 110.7M |
| Common Stock | 167K | 130K | 71K | 71K | 71K | 71K | 71K | 71K | 71K | 71K | 70.68K | 70.6K |
| Retained Earnings | -338.7M | -321.71M | -331.38M | -319.22M | -314.53M | -304.3M | -295.05M | -281.04M | -289.56M | -277.87M | -262.54M | -251.29M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -422K | -202K | -126K | -69K | -48K | -35K | 36K | -12K | -19K | 0 | -3.88K | 5.21K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |